scholarly article | Q13442814 |
P50 | author | Ronald H Gray | Q60227936 |
Thomas C. Quinn | Q72772138 | ||
Aaron A R Tobian | Q91801164 | ||
P2860 | cites work | Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial | Q21144715 |
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries | Q21261764 | ||
How does male circumcision protect against HIV infection? | Q24527278 | ||
Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis | Q24642232 | ||
Determinants and policy implications of male circumcision in the United States | Q24657711 | ||
The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda | Q37307705 | ||
Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. | Q37348083 | ||
Male circumcision and the risk of sexually transmitted infections and HIV in Rakai, Uganda. | Q38881417 | ||
Male circumcision and HIV infection in four cities in sub-Saharan Africa | Q38884144 | ||
The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations | Q39584631 | ||
The male factor in the etiology of cervical cancer among sexually monogamous women | Q41271507 | ||
Risks from circumcision during the first month of life compared with those for uncircumcised boys | Q42105347 | ||
Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). | Q43461851 | ||
Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study | Q44562491 | ||
Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya | Q45748596 | ||
The association between circumcision status and human immunodeficiency virus infection among homosexual men. | Q45777557 | ||
Human immunodeficiency virus infection in long-distance truck drivers in east Africa | Q45781694 | ||
Ignoring evidence of circumcision benefits | Q46046725 | ||
Male circumcision for HIV prevention: from evidence to action? | Q47706900 | ||
Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. | Q51329359 | ||
Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. | Q53203451 | ||
A trade-off analysis of routine newborn circumcision. | Q53340247 | ||
Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. | Q54710732 | ||
Human papillomavirus infection in men attending a sexually transmitted disease clinic. | Q54781930 | ||
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. | Q55035783 | ||
Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men | Q58281333 | ||
Circumcision and sexually transmitted diseases | Q72747147 | ||
Male circumcision and susceptibility to HIV infection among men in Tanzania | Q73331422 | ||
Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade | Q81158295 | ||
ACOG Committee Opinion. Circumcision. Number 260, October 2001 | Q95825005 | ||
Circumcision policy statement. American Academy of Pediatrics. Task Force on Circumcision | Q28137911 | ||
The increasing incidence of newborn circumcision: data from the nationwide inpatient sample | Q28235043 | ||
Neonatal circumcision: a review of the world's oldest and most controversial operation | Q28257539 | ||
Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men | Q28273487 | ||
Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis | Q28296276 | ||
Between Prophylaxis and Child Abuse: The Ethics of Neonatal Male Circumcision | Q28315365 | ||
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial | Q28972526 | ||
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial | Q29619176 | ||
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial | Q29619179 | ||
Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States | Q30233059 | ||
The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda | Q33340636 | ||
Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa | Q33651617 | ||
Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa | Q33846776 | ||
The highly protective effect of newborn circumcision against invasive penile cancer | Q33852874 | ||
New policy on circumcision--cause for concern | Q33891982 | ||
Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. | Q33926032 | ||
Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. | Q33926036 | ||
Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial | Q33999996 | ||
Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. | Q34003387 | ||
The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda | Q34008812 | ||
Adult male circumcision: effects on sexual function and sexual satisfaction in Kisumu, Kenya | Q34013600 | ||
Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. | Q34295367 | ||
Male circumcision and risk of HIV-1 and other sexually transmitted infections in India | Q34309530 | ||
Male neonatal circumcision: indications, controversies and complications | Q34341368 | ||
Potential HIV-1 target cells in the human penis | Q34548480 | ||
Circumcision status and HIV infection among Black and Latino men who have sex with men in 3 US cities | Q34718905 | ||
Is infant male circumcision an abuse of the rights of the child? Yes. | Q34722456 | ||
Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya | Q34846815 | ||
HIV-1 infection of human penile explant tissue and protection by candidate microbicides | Q35148241 | ||
Bacterial vaginosis is not associated with circumcision status of the current male partner | Q35562584 | ||
Male circumcision for prevention of HIV and other sexually transmitted diseases | Q36778390 | ||
Circumcision in the time of HIV: when is there enough evidence to revise the American Academy of Pediatrics' policy on circumcision? | Q36808392 | ||
Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention | Q37119274 | ||
Male circumcision for the prevention of HSV-2 and HPV infections and syphilis | Q37178782 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sexually transmitted infection | Q12198 |
sexual transmission | Q45349134 | ||
P304 | page(s) | 78-84 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | JAMA Pediatrics | Q4787306 |
P1476 | title | Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision | |
P478 | volume | 164 |
Q24617297 | A 'snip' in time: what is the best age to circumcise? |
Q36918159 | Antiviral immune responses in the genital tract: clues for vaccines |
Q37183060 | Attitudes and decision making about neonatal male circumcision in a Hispanic population in New York City |
Q34361423 | Circumcision - A new approach for a different cosmetic result |
Q28741995 | Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda |
Q24630822 | Costs and effectiveness of neonatal male circumcision |
Q38171861 | Counseling parents who are considering newborn male circumcision |
Q38615746 | Does Circumcision Increase Meatal Stenosis Risk? - a Systematic Review and Meta-Analysis. |
Q61805202 | Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions? |
Q37630319 | Early infant male circumcision: Systematic review, risk-benefit analysis, and progress in policy |
Q28743450 | Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda |
Q36044770 | Erectile function in circumcised and uncircumcised men in Lusaka, Zambia: A cross-sectional study |
Q35918072 | Factors Associated with Knowledge of and Willingness for Adult Male Circumcision in Changsha, China |
Q37117397 | Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-Saharan African community |
Q37118973 | Frequency and implications of HIV superinfection |
Q33788345 | HIV infection and immune defense of the penis |
Q35547098 | HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study |
Q36050122 | HIV type 1 genetic variation in foreskin and blood from subjects in Rakai, Uganda |
Q42957076 | Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition |
Q36796543 | Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin |
Q36235594 | Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa |
Q35944781 | In developed countries male circumcision prevalence is inversely related to HIV prevalence |
Q42418120 | Infant male circumcision and future health disparities |
Q35734893 | Knowledge, Attitudes, Practices and Beliefs about Medical Male Circumcision (MMC) among a Sample of Health Care Providers in Haiti |
Q46759615 | Male circumcision and HIV risk behavior among university students in northern Nigeria |
Q44752072 | Male circumcision and HPV transmission to female partners |
Q33601150 | Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda |
Q35349609 | Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda |
Q35669040 | Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda |
Q34225858 | Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa |
Q42957632 | Male circumcision for prevention of oncogenic HPV infection |
Q39571729 | Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress. |
Q35683093 | Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men. |
Q36997446 | Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda |
Q43182526 | Male circumcision: integrating tradition and medical evidence. |
Q38611015 | Minimizing Penile Implant Infection: A Literature Review of Patient and Surgical Factors |
Q92723036 | Penile Prosthesis Infection: Myths and Realities |
Q36298923 | Prepuce health and childhood circumcision: Choices in Canada |
Q41639261 | Prevention of syphilis: another positive benefit of male circumcision |
Q53418232 | Providers' Perceptions and Training Needs for Counseling Adolescents Undergoing Voluntary Medical Male Circumcision. |
Q24621538 | Review: a critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries |
Q24197530 | Routine neonatal circumcision for the prevention of urinary tract infections in infancy |
Q37939386 | Science and ethics of human immunodeficiency virus/acquired immunodeficiency syndrome controversies in Africa |
Q38854498 | Self-selection of male circumcision clients and behaviors following circumcision in a service program in Uganda |
Q36844804 | Sexually transmitted infections and male circumcision: a systematic review and meta-analysis |
Q35680389 | Social representations of male circumcision as prophylaxis against HIV/AIDS in Zimbabwe |
Q38027019 | The 2010 Royal Australasian College of Physicians' policy statement 'Circumcision of infant males' is not evidence based |
Q35580656 | The 30-year war on AIDS: have we reached the tipping point? |
Q21296754 | The Strong Protective Effect of Circumcision against Cancer of the Penis |
Q43412469 | The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV |
Q36355708 | The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding |
Q34221409 | The medical benefits of male circumcision |
Q44045974 | Veracity and rhetoric in paediatric medicine: a critique of Svoboda and Van Howe's response to the AAP policy on infant male circumcision |
Q38385581 | Voluntary medical male circumcision in resource-constrained settings |
Search more.